Heartbeam (BEAT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Jun, 2026Executive summary
Supplement details changes to board nominees for the 2026 Annual Meeting scheduled for July 31, 2026.
Two nominees, Mark Strome and Rob Eno, have withdrawn from re-election due to resignation and mutual agreement, respectively.
No replacement nominees will be named for the withdrawn candidates.
Voting matters and shareholder proposals
Shareholders who have already voted do not need to take action unless they wish to change their vote.
Proxies will remain valid, but votes will not be cast for the withdrawn nominees.
All other agenda items and voting instructions remain unaffected.
Board of directors and corporate governance
Mark Strome resigned from the board for personal reasons, effective June 18, 2026.
Rob Eno, CEO and board member, will depart as of June 30, 2026, as part of a strategic reorganization.
Both departures were not due to disputes or disagreements with company operations or policies.
Latest events from Heartbeam
- AIMIGo nears FDA clearance as Q2 loss hits $5M, cash burn raises going concern risk.BEAT
Q2 20248 Jul 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan by 3 million shares.BEAT
Proxy filing18 Jun 2026 - FDA-cleared at-home 12-lead ECG platform targets $40B market with scalable, AI-driven growth.BEAT
Investor presentation5 Jun 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan by 3 million shares.BEAT
Proxy filing5 Jun 2026 - Net loss narrowed, cash burn fell, and $11.5M funding supports clinical and commercial growth.BEAT
Q1 202613 May 2026 - FDA-cleared 12-lead ECG platform targets $40B market with at-home cardiac monitoring innovation.BEAT
Investor presentation13 May 2026 - FDA-cleared ECG tech launches with strong demand, narrowing losses, and AI-driven growth ahead.BEAT
Q4 20253 May 2026 - At-home 12-lead ECG platform launches with subscription model and AI-driven expansion.BEAT
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - FDA-cleared portable ECG system targets $100M capital raise in expanding cardiac monitoring market.BEAT
Registration Filing13 Mar 2026